CDC: Five Cases of Neonatal Enterovirus Infection Identified in San Diego
By Elana Gotkine HealthDay Reporter
FRIDAY, July 12, 2024 -- Five cases of neonatal enterovirus infection have been reported in San Diego, highlighting the risks and need for timely identification and treatment, according to data published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ryan Sanchez, M.D., from the University of California, San Diego, and colleagues describe five cases of neonatal enterovirus infection identified at Rady Children's Hospital in San Diego.
The researchers note that based on characteristic clinical presentations during enterovirus seasons, all five cases were initially suspected to be caused by enterovirus, which was supported by positive rhinovirus-enterovirus results from respiratory virus panel testing of nasopharyngeal specimens. For four of the five patients, plasma tested positive for enterovirus by reverse transcription-polymerase chain reaction (RT-PCR). Two patients had positive RT-PCR testing of cerebrospinal fluid for enterovirus. Four and three infants had thrombocytopenia and hepatitis with coagulopathy, respectively. In three neonates, serum ferritin levels were elevated. Seizures were the initial sign in one neonate, who subsequently developed pancytopenia with suspected, but unconfirmed, viral-induced hemophagocytic lymphohistiocytosis. The most severely affected patient, aged 5 days, developed multiorgan failure; his mother experienced a febrile illness during delivery, which was diagnosed as chorioamnionitis. The infant received multiple immune globulin intravenous (IGIV) doses, the investigational drug pocapavir, and maternal convalescent plasma, but did not survive. Four of the infants received IGIV therapy. Mothers of three infants were diagnosed with chorioamnionitis before delivery and the mother of the remaining two infants received a diagnosis of endometritis.
"Timely identification facilitates optimal clinical management for the infant, which might include receipt of IGIV and possibly antiviral medication," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Recent Years Saw Increase in U.S. Pregnancy-Related Deaths
FRIDAY, April 18, 2025 -- During 2018 to 2022, pregnancy-related deaths in the United States increased, according to a study published online April 9 in JAMA Network Open. Yingxi...
Twins Have Less Fat Accumulation Than Singletons Beginning in Early Pregnancy
THURSDAY, April 17, 2025 -- Twins have proportionally less fat tissue accumulation in utero compared with singletons as early as 15 weeks of gestation, according to a study...
Incidence of Neonatal Herpes Simplex Virus Infections in U.S. 15.7 Per 100,000 Births in 2019
TUESDAY, April 15, 2025 -- The incidence of neonatal herpes simplex virus (nHSV) infections in the United States in 2019 was 15.7 per 100,000 hospital births, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.